During the past decade, MultiCare Regional Cancer Center - Auburn conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MultiCare Regional Cancer Center - Auburn" #1 collaborator was "ARMO BioSciences" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "MultiCare Regional Cancer Center - Auburn" are "Non Small Cell Lung Cancer" (2 trials), "Ovarian Neoplasms" (2 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "MultiCare Regional Cancer Center - Auburn" in a lesser frequency.

Most popular intervention types in "MultiCare Regional Cancer Center - Auburn" are "Drug" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Pegilodecakin" (3 trials), "Doxorubicin HCl Liposome Injection" (1 trials), "FOLFOX" (1 trials), "Nivolumab" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "MultiCare Regional Cancer Center - Auburn" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "MultiCare Regional Cancer Center - Auburn". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in MultiCare Regional Cancer Center - Auburn, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MultiCare Regional Cancer Center - Auburn, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".